Hilma J van der Horst

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Monoclonal Antibody

Drug Administration

Cell Proliferation

Epstein Barr Virus

Top Venues

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Hilma J van der Horst, A Vera de Jonge, Ida H Hiemstra, Anne T Gelderloos, Daniella R A I Berry, Nathalie J Hijmering, Hendrik F van Essen, Daphne de Jong, Martine E D Chamuleau, Sonja Zweegman, Esther C W Breij, Margaretha G M Roemer, Tuna Mutis
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment. Blood cancer journal 11 (2) (2021)
Hilma J van der Horst, Inger S Nijhof, Tuna Mutis, Martine E D Chamuleau
Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies. Cancers 12 (10) (2020)